About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

End-stage Renal Disease (ESRD) Pilot Study

NCT03787368·15 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bayer

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male and female patients between 18 and 80 years of age.
ESRD on hemodialysis (including hemodiafiltration) for at least 3 months
Life expectancy of \> 6 months
Women of non-childbearing potential

You may not be if

High risk for clinically significant bleeding
Acute renal failure
Planned major surgery in the next 7 months from randomization
Concomitant use of oral anticoagulant therapy or antiplatelet therapy
Documented thrombotic event in the past 6 months

The record

StatusCompleted

PhasePhase 1

Taking part55

StartedJan 2019

UpdatedMar 16, 2022

Conditions

Where15

California Institute of Renal Research - Chula Vista
Chula Vista, California, United States
Nova Clinical Research, LLC
Bradenton, Florida, United States
Research by Design, LLC
Chicago, Illinois, United States

Clareo Health | End-stage Renal Disease (ESRD) Pilot Study